Healthcare AI

China's healthcare AI market is driven by scale: hospitals with tens of thousands of daily outpatients, a national insurer, and consumer platforms such as Ant Group's Afu that reach over a hundred million users. Clinical AI research is published from provincial tumour hospitals as much as from Beijing and Shanghai, and AI-for-science drug discovery startups spun out of Tsinghua and other universities are raising large angel rounds.

This page gathers our healthcare entries: pre-operative risk models developed with hospitals, patient-management products with named clinical partners, drug discovery funding rounds, and consumer health apps with disclosed user counts. We record the hospital, the trial status and the funding amount in dollars where available.